Matches in Nanopublications for { ?s ?p "[TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1045370.RAcprGy_63tYPaEUf3fhf3CEoE_PzDro_xcmDDDNOMTV8130_assertion description "[TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1045370.RAcprGy_63tYPaEUf3fhf3CEoE_PzDro_xcmDDDNOMTV8130_provenance.
- NP1045371.RAQ9D-MEzHzPF1rzBJMw89PWJed_qM0Ajzy4blCrCZSPI130_assertion description "[TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1045371.RAQ9D-MEzHzPF1rzBJMw89PWJed_qM0Ajzy4blCrCZSPI130_provenance.
- NP1045372.RAZWhLHdfXhS3hUahICWBLtRIW6J3TOuheJYOvhx8GX90130_assertion description "[TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1045372.RAZWhLHdfXhS3hUahICWBLtRIW6J3TOuheJYOvhx8GX90130_provenance.
- NP738049.RAs2y8tTxNh3KVm16DVMsF3TZrMGbTgMog8TfUApt18E0130_assertion description "[TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738049.RAs2y8tTxNh3KVm16DVMsF3TZrMGbTgMog8TfUApt18E0130_provenance.
- NP737529.RA99GH8gxrcaw64ymvYXAjUKCBFgud-fUyEuojQB0ir-Q130_assertion description "[TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP737529.RA99GH8gxrcaw64ymvYXAjUKCBFgud-fUyEuojQB0ir-Q130_provenance.
- NP1045369.RA9463hBp8rFXol1j2jaZBv1aCynYXxrdXNVsXIWvEmfY130_assertion description "[TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1045369.RA9463hBp8rFXol1j2jaZBv1aCynYXxrdXNVsXIWvEmfY130_provenance.